iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Torrent Pharmaceuticals Limited - Appointment

11 May 2022 , 12:00 AM

Torrent Pharmaceuticals Limited has informed the Exchange about Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its meeting held on 11-May-22, has appointed Dr. Maurice Chagnaud as an Additional and Independent Director of the Company for a term of 3 consecutive years effective from 11-May-22, subject to approval of the shareholders of the Company.

Related Tags

  • Announcements
  • BSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Titagarh Rail Q3 Profit Falls 16% YoY
13 Feb 2025|11:34 PM
Shilpa Medicare Gets CDSCO Nod for NAFLD Drug
13 Feb 2025|11:09 PM
Hindalco Q3 Profit Soars 75% YoY
13 Feb 2025|10:53 PM
ITD Cementation Q3 Profit Rises 11% YoY
13 Feb 2025|05:05 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.